<?xml version="1.0" encoding="UTF-8"?>
<p id="JVEv5-para-0116">Pablo Tebas (University of Pennsylvania, USA) presented recent progress in advancing HIV-1 gene therapy. Gene engineering of autologous CD4 T cells or CD34
 <sup>+ </sup>hematopoietic stem cells to block HIV-1 infection has been a popular approach. The method uses strategies that involve harvesting cells from patients, manipulation and selection 
 <italic>ex vivo</italic> followed by reinfusion 
 <xref rid="JVEv5-bib-0027" ref-type="bibr">[27]</xref>. Valuable information for developing this technology was derived from the understanding of processes underlying the cure of Timothy Brown, the ‘Berlin patient’.
</p>
